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The genus Penicillium is among the most promising alkaloid-producing fungal and therefore 
plays an important role in terms of producing molecules with biotechnological potential. Thus, in 
order to identify alkaloid-producing fungi, 25 endophytic Penicillium strains previously isolated 
from Amazon medicinal plants were subject to an integrative approach based on direct infusion 
positive electrospray ionization mass spectrometry (ESI-MS) and principal component analysis 
(PCA). The multivariate analysis pointed paxiline (1), glandicoline B (2), roquefortine C (3), and 
oxaline (5) as responsible for the segregation of three promising alkaloid-producing groups, been 
these groups constituted for P. chrysogenum, P. oxalicum, P. paxilli, and P. rubens strains. These 
alkaloids and the glandicoline A (4) were tentatively identified by multiple-stage mass spectrometry. 
In addition, compounds 1 and 2 were isolated and confirmed by using 1D and 2D nuclear magnetic 
resonance (NMR) spectroscopy. Overall, the chemical profile analysis by ESI-MS along with PCA 
provided a simple and effective approach to screening alkaloid-producing Penicillium strains for 
biotechnological applications.
Keywords: glandicoline, paxilline, Penicillium oxalicum, Penicillium paxilli, Penicillium rubens, 
oxaline
Introduction
Fungi are widely distributed throughout the planet 
integrating the biogeological cycles of all ecosystems.1 
They comprise a wide variety of species, around 
3.8  million, distributed mainly on environments such 
as in soil, water, and associated with plants and others 
organisms.2 When associated with plants they are known 
as endophytics, and live in the inter and intracellular 
spaces of this individual for at least a period of their 
life cycle.3 Usually, they have a symbiotic association 
with the plants that protect and provide nutrients to 
the endophyte, which, in turn, benefit the host through 
the control of pathogens as well as in the absorption of 
nutrients and the production of phytohormones.4 Thus, 
endophytes not only provide advantages to the host but 
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also are sources of new metabolites with diverse biological 
activities.5 Among these endophytes, some genus as 
Aspergillus, Trichoderma, Fusarium, and Penicillium 
stand out in terms of producing molecules with 
several biotechnological potentials, such as antibiotics, 
antioxidants, and antitumoral agents.6-9
Since the discovery of the penicillin in 1929, the 
genus Penicillium, which is composed by approximately 
354 known species,10 has been described as a promising 
source of bioactive compounds, such as polyphenols, 
polyketides, and alkaloids.11-13 Alkaloids produced by 
Penicillium has been showed potential to biotechnological 
applications, been their antimicrobial, antiviral, and 
anticancer activities previously described.14-18
The prospection of bioactive compounds or new 
molecules from microorganisms is an important and complex 
task, which usually demands modern analytical techniques 
with high sensitivity and selectivity, such as that based on 
mass spectrometry (MS).19,20 In the recent years, these mass 
spectrometry-based approaches has been proved to be a 
powerful strategy for the screening and identification of 
bioactive compounds in plant and microorganism species as 
well as to chemotaxonomic approaches, when combined with 
chemometric tools.21-23 Thus, in this study, 25 endophytic 
Penicillium strains previously isolated from Amazon 
medicinal plants were screened for alkaloid-producing by 
an integrative approach based on direct infusion positive 
electrospray ionization mass spectrometry (ESI-MS) and 
principal component analysis (PCA).
Experimental
Fungal cul t ivat ion and micro-scale metabol i tes 
extraction 
The 25 strains previously isolated from Brazilian 
medicinal plants are deposited in the work collection of 
the Amazon Bioassay and Microorganism Laboratory 
from Amazon Federal University (LabMicra/UFAM) 
and has the access to genetic heritage registered at 
Sistema Nacional de Gestão do Patrimônio Genético e do 
Conhecimento Tradicional Associado (SisGen) under the 
code No. AD64E07 (Table 1). They were grown in Petri 
dishes containing ISP2 medium (10 g corn starch, 4 g yeast 
extract, 10 g malt, 4 g dextrose, and 20 g agar for every 1 L 
of distilled water) for 10 days at 26 ºC. 
After the cultivation period, three plugs of 6 mm 
diameter were removed from each plate and transferred 
to 5 cm test tubes and extracted for 24 h with 2 mL of a 
solution containing 3:2:1 ethyl acetate/dichloromethane/
methanol, with 1% formic acid.24 The solvent was then 
filtered through a small piece of cotton and concentrated, 
yielding around 1 mg of extract in general for all samples.
Fungal cultivation and large-scale metabolites extraction 
For the fungal metabolic production, two strains with 
even peaks in their mass-spectra profiles, P. paxilli (O) 
and P. rubens (V), were cultivated in preparative scale, 
using 60 Erlenmeyer flasks of 1 L containing 300 mL of 
ISP2 liquid medium each. The cultivation was made at 
26 ºC in static mode for 23 days. pH and glucose were 
measured in the beginning of the cultivation and in the end. 
After the cultivation period, the crude fermentation broth 
was separated from the mycelium by vacuum filtration. 
Extraction of the fermentation broth (18 L) was performed 
with ethyl acetate (3 × 500 mL),25 providing the organic 
phase that was concentrated, yielding 1.3 g of crude extract 
for the P. paxilli and 1.9 g for the P. rubens. Both extracts 
were stored at 4 ºC.
Table 1. Endophytic Penicillium strains subjected to alkaloidal screening
Strain ID
ID in the work 
collection
Host (plant) Part of the plant
A GhcR3 2.2 (401) Gustavia elliptica root bark
B PbR2 2.2 (135) Mauritia flexuosa root
C GhcR1 1.1a (415) G. elliptica root bark
D GhcC1 1.2c (414) G. elliptica stem bark
E StspC2 1.2c (180) Strychnos sp. stem
F GhR1 2.1 (391) G. elliptica root
G VrF1 2.2 (64) Victoria amazonica leaf
H AspC2 2.2 (52) Annona sp. stem
I AnspG1 2.2 (56) Annona sp. twig
J GhcR1 1.1b (433) G. elliptica root bark
K AnspG1 2.3b (155) Annona sp. twig
L VrF2 2.3 (149) V. amazonica leaf
M VrC2 2.1c (143) V. amazonica stem
N GhG2 2.1 (392) G. elliptica twig
O AnspG1 2.3a (153) Annona sp. twig
P AnspC2 3.1 (38) Annona sp. stem
Q GhR1 2.1a (396) G. elliptica root
R GhcG3 2.2 (457) G. elliptica twig bark
S GhR2 1.2b (408) G. elliptica root
T VrC2 1.2 (71) V. amazonica stem
U AnspcG1 3.3 (48) Annona sp. twig bark
V GhcR3 2.2 (403) G. elliptica root bark
W GhG3 2.2c (407) G. elliptica twig
X EjC3 2.1a (307) Piper peltata stem
Y GhcC2 2.2a (409) G. elliptica stem bark
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ESI-MS and PCA analysis
The micro-scale extracts were resuspended in methanol 
(HPLC grade), creating the stock solutions (1 mg mL-1). 
Aliquots (5 µL) of the stock solutions were further diluted 
to 5 µg mL-1 and analyzed by direct infusion into the mass 
spectrometers. An ion-trap mass spectrometer, model LCQ 
Fleet (Thermo Scientific, San Jose, CA, USA), equipped 
with electrospray ionization (ESI) interface and running in 
the positive ion mode was used to perform ESI-MS and a 
triple quadrupole mass spectrometer, model TSQ Quantum 
Access (Thermo Scientific, San Jose, CA, USA) to perform 
ESI-MS/MS analyses. Samples were directly infused 
into the ion source through the instrument syringe pump 
(10  µL  min-1). MS analytical conditions: spray voltage, 
5 kV; sheath gas, 10 arbitrary unit (arb); auxiliary gas, 5 arb; 
sweep gas, 0 arb; capillary temp, 200 ºC; capillary voltage, 
40 V; tube lens, 115 V; mass range, m/z 150 to 1000. Argon 
was used as collision gas, and the ESI-MS/MS spectra 
were obtained using collision energies ranging from 25 
to 30 eV. For the principal component analysis (PCA), 
initially, the relative ion intensity obtained by ESI-MS 
from m/z 150 to 1000 (850 variables) was analyzed through 
Chemoface™ program.21,22,26 In order to highlight only the 
alkaloid-producing strains groups, a new PCA analysis was 
performed based only in the relative intensity of even ions 
(426 variables). 
Alkaloids isolation
P. paxilli crude extract (1.3 g) was subjected to 
silica gel column chromatography (CC) with increasing 
gradient of polarity: hexane-ethyl acetate (70:30, 30:70, 
and 0:100, v/v), ethyl acetate-methanol (80:20 and 
0:100, v/v), affording 5 fractions (50 mL each). Fraction 2 
(PP.F2) (97 mg) was subjected to C18 CC eluted with 
water-methanol (50:50 to 0:100, v/v), giving 5 fractions 
(50  mL  each). Then, the fractions 3 (PP.F2.3, 18 mg) 
and 4 (PP.F2.4, 10 mg) were pooled into a new fraction 
(PP.F2.3-4, 28 mg) according to MS analysis. PP.F2.3-4 
was submitted to a semi-preparative Shimadzu high-
performance liquid chromatography (HPLC), model 
UFLC (Shimadzu, Columbia, MD, USA), using water (A) 
and methanol (B) as mobile phases. The gradient elution 
was as follows: 0-10 min, 70-100% B (v/v) and 10-25 min, 
100% B at a flow rate of 3.4 mL min-1. A C18 column 
(250 × 10 mm, 5 m) was employed on the fractionation 
and the UV channels at 280 and 232 nm were monitored. 
A single injection was carried onto the column in dimethyl 
sulfoxide (DMSO, 150 μL), yielding compound 1 (13 mg) 
as an amorphous white solid.
Similarly, P. rubens crude extract (1.9 g) was subjected 
to C18 CC eluted with water-methanol (70:30, 30:70, 
and 0:100, v/v), affording 3 fractions (50 mL each). 
Fraction  2  (PR.F2) (470 mg) was subjected to C18 CC 
and eluted with water-methanol (60:40, 40:60, and 0:100, 
v/v), giving 3 fractions (50 mL each). Then, fraction 2 
(PR.F2-2) (80  mg) was subjected to over C18 CC and 
eluted with water-methanol (50:50 and 0:100, v/v), giving 
2 fractions (50 mL each). Finally, fraction 1 (PR.F2-2-1) 
(30 mg) was submitted to a semi-preparative HPLC, model 
UFLC (Shimadzu, Columbia, MD, USA), using water (A) 
and methanol (B) as mobile phases. The gradient elution 
was as follows: 0-45 min, 45-59% B (v/v), 45-50 min, 
59-100% B (v/v), and 50-70 min, 100% B (v/v) at a flow 
rate of 3.4 mL min-1. The same C18 column above was 
employed on the fractionation and the UV channels at 
240 and 300 nm were monitored. A single injection was 
carried onto the column in DMSO (150 μL), which afforded 
compound 2 (5 mg) as an amorphous yellow solid.
NMR analysis
The one-dimensional (1D) and two-dimensional 
(2D) nuclear magnetic resonance (NMR) analysis were 
performed with an AVANCE III HD 500 NMR spectrometer 
(Bruker, Billerica, MA, USA), operating at 11.75 T, 
observing 1H at 500.13 and 13C at 125.76 MHz. Deuterated 
methanol (MeOD) (Cambridge Isotope, Tewksbury, MA, 
USA) was used as solvent. All chemical shifts (d) are given 
in ppm relative to the solvent signal, and the coupling 
constants (J) are given in Hz.
Microorganism identification
The identification of the alkaloid-producing Penicillium 
strains was confirmed by sequencing of the fungus internal 
transcribed space-1 (ITS) and ITS-2 rDNA and compared 
with sequences from the GenBank. 10 μL of the strains 
spore suspension concentrated in 30 × 108 cells mL-1 was 
incubated on 50 mL potato dextrose (PD), medium in a 
125 mL Erlenmeyer and stirred for 36 h (120 rpm) at 26 ºC 
temperature. The mycelium was separated from the medium 
by filtration and crushed with silica gel and then preceded 
to extraction. The total deoxyribonucleic acid (DNA) was 
extracted by a Zymo Research Quick-DNA™ Fungal/
Bacterial Miniprep Kit using its own protocol with some 
adaptations, using 50 μL of the DNA dilution buffer instead 
of protocol’s 100 μL and using longer centrifugation times 
on all steps. After the extraction, the DNA was sequenced 
using a model 3500 Genetic Analyzer (Applied Biosystems, 
Foster city, CA, USA). All the data was then analyzed 
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and processed using National Center for Biotechnology 
Information’s (NCBI) Nucleotide Basic Local Alignment 
Search Tool (BLASTn) tool (Table 2).
Results and Discussion
The direct infusion ESI positive mass spectra of the 
Penicillium strains crude extracts from m/z 150 to 1000 
displayed several base peak ions in the range of 400-800 Da 
(Figures S1 to S25, Supplementary Information (SI) 
section), such as m/z 420, 448, and 458, suggesting the 
presence of alkaloids in a large portion of the samples. 
This proposal was based on previous studies with fungal 
alkaloids containing an odd number of nitrogen atoms, 
such as indole alkaloids, where protonation process 
provides products with even m/z values.23,27,28 Besides base 
peak, several other ions were observed, indicating these 
samples as complex matrixes. In the first PCA score plot 
(Figure 1a), based on the relative intensity of m/z 150 to 
1000 (850 variables), five main groups (group I-V) were 
observed, being group I formed by three strains, group II 
by eight strains, group III by three strains, group IV by four 
strains and group V by seven strains. On the other hand, 
the second PCA score plot (Figure 1b), based on only the 
relative intensity of even ions (426 variables), highlighted 
the groups I, III, and IV as discrete alkaloid-producing 
groups. The groups II and V became together in this graph, 
reveling to be similar in the production of alkaloids. In fact, 
the strains of these groups have shown low intense even 
ions, reveling to be poor alkaloid producers, at least in the 
grown conditions used.
According to the PCA biplot (PC2 × PC3) of scores 
and loadings (Figure 1c), the ions at m/z 390, 420, 448, and 
458 were the main responsible for the segregation of the 
groups I, III, and IV. The MS/MS spectra of some of these 
ions (Figure 2) revealed key fragmentations (losses of 68 
or 69 Da) previously described for prenylated alkaloids, 
such as roquefortine and related compounds.17,27 
The MS/MS spectrum of the ion at m/z 390 (Figure 2a) 
displayed, besides the initial loss of the prenyl group 
(-68 Da, m/z 390 → 322), a base peak at m/z 193, which 
is in accordance with the structure of roquefortine C (3) 
(Figure 3).27 The MS/MS spectrum of the ion at m/z 420 
(Figure 2b) also displayed the initial loss of the prenyl 
group (-69 Da, m/z 420 → 351), as well as a base peak 
at m/z 289, being this fragmentation consistent with the 
structure of glandicoline B (2) (Figure 3).17 Moreover, 
the MS/MS spectrum of the ion at m/z 448 (Figure 2c) 
displayed an initial loss of a methoxyl group (-31 Da, 
m/z  448 →  417), followed by a loss of a prenyl group 
(-69 Da, 417 → 348), which is in accordance with the 
structure of the alkaloid oxaline (5) (Figure 3).23 On the 
other hand, the MS/MS spectrum of the ion at m/z 458 
do not generate fragments, even increasing the collision 
energy. Since this phenomenon is recurrent for sodium 
adduct molecular ions,28 the sodium mass was taken into 
consideration, and the correspondent protonated ion at 
m/z  436 was submitted to MS/MS analysis. Thus, the 
MS/MS spectrum of the ion at m/z 436 (Figure 2d) 
presented a base peak at m/z 130 and a less intense ion at m/z 
182, being this fragmentation consistent with the structure 
of paxilline (1) (Figure 3).28 Paxilline (1), as well as 
glandicoline B (2), were also confirmed by a comparison of 
their NMR data (SI section, Figures S32 to S39, Tables S1 
and S2) with those reported in the literature.17,29,30
Besides, after a manual inspection of the MS spectra 
from group III, a minor ion at m/z 404 was tentatively 
identified as glandicoline A (4), the precursor of the 
glandicoline B. Thus, the MS/MS spectrum of 4 (Figure 2e) 
presented a loss of prenyl group (-69 Da, m/z 404 → 335) 
as well as the base peak at m/z 319, in coherence with the 
structure of glandicoline A.27
Since the alkaloids 1-5 were tentatively identified 
between strains from the groups I (H, O, and X), III (B, 
N, and V), and IV (G, L, M, and T), these organisms were 
assigned as alkaloid-producing strains and identified 
Table 2. Species identification of nine Penicillium endophytic strains by molecular approach with NCBI’s BLASTn information
Strain ID Group Description Max score Total score Query cover / % Expect value Percent identity / %
H I P. paxilli 990 1165 99 0 100.00
O I P. paxilli 979 979 100 0 100.00
X I P. paxilli 924 924 98 0 99.22
B III P. chrysogenum 977 1082 100 0 100.00
V III P. rubens 1195 1517 100 0 98.12
N III P. rubens 1042 1042 99 0 100.00
G IV P. oxalicum 761 761 100 0 98.61
L IV P. oxalicum 911 911 99 0 99.80
M IV P. oxalicum 979 979 100 0 100.00
T IV P. oxalicum 952 952 98 0 99.81
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by molecular approach (Table 2). Using the BLASTn it 
was possible to identify the strains H, O, and X of the 
group I as P. paxilli, a fungus known to produce indole 
diterpene alkaloids, such as paspaline, paxilline (1) and 
derivates.29,31 Likewise, the strain B, from the group III, 
was identified as P. chrysogenum, while the strains N 
Figure 1. PCA score plots (a and b) and biplot of scores and loadings (c) generated from the crude extract ESI-MS data from twenty-five endophytic 
Penicillium strains from Amazon medicinal plants (A-Y). 
Figure 2. ESI-MS/MS spectra (positive mode) of the ion at m/z 390 (a), 420 (b), 448 (c), 436 (d), and 404 (e), present in the crude extracts of Penicillium 
strains.
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and V were identified as P. rubens. These two fungal 
species are genetically and chemically close, and has 
been described as promising sources of diketopiperazine 
alkaloids, such as roquefortines (2-4) and other alkaloids 
with biotechnological potential.32 By its turn, the strains 
G, L, M, and T of the group IV were identified as 
P. oxalicum, which is also known to produce roquefortine 
alkaloids, however towards the end of the pathway such 
as meleagrin and oxaline (5).33 These observations suggest 
a close biosynthetic relationship between the strains from 
the groups III and IV. Surprisingly, all species from the 
group IV were isolated from the same host (V. amazonica), 
suggesting that the host can play a role in the metabolites 
production or the selection of its fungi community. 
Paxilline is a indole diterpene alkaloid firstly described in 
P. paxilli,29 and also found in P. tularense, Acremonium lorii, 
Emericella desertorum, E. foveolata, and E. striata.34,35 It is 
known to have tremorgenic, anticonvulsant and antiinsectan 
activity.36-38 Paxilline is also a calcium-activated K+ channel 
blocker (BK), that has showed to attenuate thalidomide-
caused synaptic and cognitive dysfunctions in mice.39 On 
the other hand, glandicoline B is an important intermediate 
of the roquefortine-oxaline biosynthetic pathway.33 
Glandicoline B is a precursor of the diasteromeric pair 
oxaline (5) and neoxaline, both with anticancer activities 
against leukemic Jurkat cells through the inhibition of cell 
proliferation and arrest the cell cycle at the G2/M phase.40 
Glandicoline B was first described in P. glandicola41 and 
was later reported in P. hirsutum, P.  alli, P. radiocolor, 
P. tulipae, and P. chrysogenum.42,43 On the other hand, 
roquefortine C (3) is a relatively common fungal metabolite 
and has been reported in at least 30 fungal strains, being 
first reported in a strain of P. roquefortii.44-46 It is considered 
as one of the most common fungal contaminants of cheese, 
beverages and meats.47 Although it is considered a toxin, 
at low concentrations it was found to be safe for human 
consumption.48 Moreover, roquefortine C possesses 
neurotoxic and antimicrobial activities, most likely 
through inactivation of cytochrome P450s.49,50 The isolated 
compounds were characterized by 1H and 13C NMR and 
the data are presented in the SI section (Figures S32 to 
S39), including the NMR assignments (Tables S1 and S2).
Conclusions
The present work demonstrated the potential of several 
endophytic Penicillium strains from Amazon medicinal 
plants as alkaloid producers, including P. chrysogenum, 
P.  paxilli, P. rubens, and P. oxalicum. Moreover, the 
proposed approach based on the chemical profile by 
ESI-MS in combination with PCA analysis provided a 
simple and effective strategy for discriminate Penicillium 
strains able to produce different types of alkaloids with 
biotechnological potential. 
Supplementary Information
Supplementary information, including the 1H and 13C 
NMR data for the isolated compounds (MS and NMR data, 
Figures S1 to S39, NMR assignments (Tables S1 and S2)) is 
available free of charge at http://jbcs.sbq.org.br as PDF file.
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